Citable company snapshot
DEXCOM INC's latest SEC-sourced 2026-03-31 period shows $1.19B in revenue and $199.50M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:RevenueFromContractWithCustomerExcludingAssessedTax | Mar 31, 2026 | $1.19B | $1.26B | -5.4% |
| xbrl:GrossProfit | Mar 31, 2026 | $750.30M | $792.70M | -5.3% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $255.30M | $323.00M | -21.0% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $199.50M | $267.30M | -25.4% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $525.60M | $294.00M | +78.8% |
| Free Cash Flow (computed) | Mar 31, 2026 | $449.00M | $192.10M | +133.7% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed Apr 30, 2026; accession 0001093557-26-000073.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
